Cargando…
Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?
Biomarkers are playing a progressively leading role in both clinical practice and scientific research in dementia. Although amyloid and tau biomarkers have gained ground in the clinical community in recent years, neurodegeneration biomarkers continue to play a key role due to their ability to identi...
Autores principales: | Ferrando, Rodolfo, Damian, Andres |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141564/ https://www.ncbi.nlm.nih.gov/pubmed/34040574 http://dx.doi.org/10.3389/fneur.2021.629442 |
Ejemplares similares
-
Clinical Impact of PET With (18)F-FDG and (11)C-PIB in Patients With Dementia in a Developing Country
por: Damian, Andres, et al.
Publicado: (2021) -
Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?
por: Abualhasan, Ahmed, et al.
Publicado: (2019) -
CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
por: Körtvelyessy, Peter, et al.
Publicado: (2018) -
Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis
por: Körtvelyessy, Peter, et al.
Publicado: (2018) -
Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)